Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking

Cocaine use disorder represents a public health crisis with no FDA-approved medications for its treatment. A growing body of research has detailed the important connections between the brain and the resident population of bacteria in the gut, the gut microbiome in psychiatric disease models. Acute depletion of gut bacteria results in enhanced reward in a mouse cocaine place preference model, and repletion of bacterially-derived short-chain fatty acid (SCFA) metabolites reverses this effect. However, the role of the gut microbiome and its metabolites in modulating cocaine-seeking behavior after prolonged abstinence is unknown. Given that relapse prevention is the most clinically challenging issue in treating substance use disorders, studies examining the effects of microbiome manipulations in relapse-relevant models are critical. Here, Sprague-Dawley rats received either untreated water or antibiotics to deplete the gut microbiome and its metabolites. Rats were trained to self-administer cocaine and subjected to either within-session threshold testing to evaluate motivation for cocaine or 21 days of abstinence followed by a cue-induced cocaine-seeking task to model relapse behavior. Microbiome depletion did not affect cocaine acquisition on an FR1 schedule. However, microbiome-depleted subjects exhibited significantly enhanced motivation for low dose cocaine on a within-session threshold task. Similarly, microbiome depletion increased cue-induced cocaine-seeking following prolonged abstinence. In the absence of a normal microbiome, repletion of bacterially-derived SCFA metabolites reversed the behavioral and transcriptional changes associated with microbiome depletion. These findings suggest that gut bacteria, via their metabolites, are key regulators of drug-seeking behaviors, positioning the microbiome as a potential translational research target.

[1]  J. Cryan,et al.  The gut microbiota alone and in combination with a social stimulus regulates cocaine reward in the mouse , 2022, Brain, Behavior, and Immunity.

[2]  A. Godino,et al.  Changes in gut microbiome composition drive fentanyl intake and striatal proteomic changes , 2022, bioRxiv.

[3]  V. Sperandio,et al.  Gut colonization by Proteobacteria alters host metabolism and modulates cocaine neurobehavioral responses. , 2022, Cell host & microbe.

[4]  A. Macpherson,et al.  Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. , 2021, Cell metabolism.

[5]  D. D. Kiraly,et al.  Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine , 2021, Neuropsychopharmacology.

[6]  D. D. Kiraly,et al.  Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders , 2021, Neuropharmacology.

[7]  Mingzhi Zhang,et al.  Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms , 2021, Clinical Medicine Insights. Oncology.

[8]  D. D. Kiraly,et al.  The role of gut-immune-brain signaling in substance use disorders. , 2020, International review of neurobiology.

[9]  E. Hsiao,et al.  The maternal microbiome modulates fetal neurodevelopment in mice , 2020, Nature.

[10]  O. George,et al.  Depletion of the Microbiome Alters the Recruitment of Neuronal Ensembles of Oxycodone Intoxication and Withdrawal , 2020, eNeuro.

[11]  S. Berger,et al.  ALCOHOL METABOLISM CONTRIBUTES TO BRAIN HISTONE ACETYLATION , 2019, Nature.

[12]  Mitchell H. Murdock,et al.  The microbiota regulate neuronal function and fear extinction learning , 2019, Nature.

[13]  Sabita Roy,et al.  Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome , 2019, Proceedings of the National Academy of Sciences.

[14]  B. Vervliet,et al.  The role of short-chain fatty acids in microbiota–gut–brain communication , 2019, Nature Reviews Gastroenterology & Hepatology.

[15]  A. Uitterlinden,et al.  Relationship between gut microbiota and circulating metabolites in population-based cohorts , 2019, Nature Communications.

[16]  D. D. Kiraly,et al.  A potential role for the gut microbiome in substance use disorders , 2019, Psychopharmacology.

[17]  T. Spector,et al.  Interplay between the human gut microbiome and host metabolism , 2019, Nature Communications.

[18]  S. Russo,et al.  Neuroimmune mechanisms of psychostimulant and opioid use disorders , 2018, The European journal of neuroscience.

[19]  E. Hsiao,et al.  The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence , 2018, Neuropsychopharmacology.

[20]  Sabita Roy,et al.  Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model , 2018, Scientific Reports.

[21]  I. Amit,et al.  Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner , 2017, Cell.

[22]  T. Dinan,et al.  The microbiome regulates amygdala-dependent fear recall , 2017, Molecular Psychiatry.

[23]  E. Nestler,et al.  Neuroepigenetics and addiction. , 2018, Handbook of clinical neurology.

[24]  E. Nestler,et al.  Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine , 2018, Nature Communications.

[25]  JaneR . Taylor,et al.  Circuit and Synaptic Plasticity Mechanisms of Drug Relapse , 2017, The Journal of Neuroscience.

[26]  T. Dinan,et al.  Brain-Gut-Microbiota Axis and Mental Health , 2017, Psychosomatic medicine.

[27]  T. Abel,et al.  ACETYL-COA SYNTHETASE REGULATES HISTONE ACETYLATION AND HIPPOCAMPAL MEMORY , 2017, Nature..

[28]  E. Hsiao,et al.  Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder , 2017, Biological Psychiatry.

[29]  W. Dewey,et al.  The effect of gut microbiome on tolerance to morphine mediated antinociception in mice , 2017, Scientific Reports.

[30]  Sara R. Jones,et al.  Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration , 2017, Neuropsychopharmacology.

[31]  P. Mews,et al.  Cross-talk between the epigenome and neural circuits in drug addiction. , 2017, Progress in brain research.

[32]  T. Dinan,et al.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides , 2017, Neurotherapeutics.

[33]  T. Dinan,et al.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome , 2017, Neuropsychopharmacology.

[34]  Rita Z. Goldstein,et al.  Incubation of Cue-Induced Craving in Adults Addicted to Cocaine Measured by Electroencephalography. , 2016, JAMA psychiatry.

[35]  Y. Shaham,et al.  Translational Research on Incubation of Cocaine Craving. , 2016, JAMA psychiatry.

[36]  E. Nestler,et al.  Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine , 2016, Scientific Reports.

[37]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[38]  G. Hong,et al.  Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress , 2016, Neuroscience Letters.

[39]  T. Dinan,et al.  Regulation of prefrontal cortex myelination by the microbiota , 2016, Translational Psychiatry.

[40]  T. Dinan,et al.  Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala , 2015, Brain, Behavior, and Immunity.

[41]  M. Surette,et al.  Microbiota and host determinants of behavioural phenotype in maternally separated mice , 2015, Nature Communications.

[42]  T. Dinan,et al.  Bifidobacteria modulate cognitive processes in an anxious mouse strain , 2015, Behavioural Brain Research.

[43]  I. Amit,et al.  Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.

[44]  M. Kaplitt,et al.  The Nucleus Accumbens: A Comprehensive Review , 2015, Stereotactic and Functional Neurosurgery.

[45]  T. Dinan,et al.  Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.

[46]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[47]  Hanspeter Pfister,et al.  UpSet: Visualization of Intersecting Sets , 2014, IEEE Transactions on Visualization and Computer Graphics.

[48]  D. Macfabe,et al.  Enteric Bacterial Metabolites Propionic and Butyric Acid Modulate Gene Expression, Including CREB-Dependent Catecholaminergic Neurotransmission, in PC12 Cells - Possible Relevance to Autism Spectrum Disorders , 2014, PloS one.

[49]  Jun Sun,et al.  Exploring gut microbes in human health and disease: Pushing the envelope , 2014, Genes & diseases.

[50]  Jimmy D Bell,et al.  The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism , 2014, Nature Communications.

[51]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[52]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[53]  D. Macfabe,et al.  Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders , 2012, Microbial ecology in health and disease.

[54]  Y. Shaham,et al.  Neurobiology of the incubation of drug craving , 2011, Trends in Neurosciences.

[55]  K. McCoy,et al.  The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. , 2011, Gastroenterology.

[56]  E. Oleson,et al.  Behavioral Economic Assessment of Price and Cocaine Consumption Following Self-Administration Histories which Produce Escalation of Either Final Ratios or Intake , 2008, Neuropsychopharmacology.

[57]  D. Schrenk,et al.  Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. , 2008, The Journal of nutritional biochemistry.

[58]  B. Nankova,et al.  Differential regulation of the tyrosine hydroxylase and enkephalin neuropeptide transmitter genes in rat PC12 cells by short chain fatty acids: Concentration-dependent effects on transcription and RNA stability , 2007, Brain Research.

[59]  Francis Boon,et al.  Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders , 2007, Behavioural Brain Research.

[60]  B. Nankova,et al.  Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein , 2006, Brain Research.

[61]  Swati Gandhi,et al.  Stereospecific Regulation of Tyrosine Hydroxylase and Proenkephalin Genes by Short-Chain Fatty Acids in Rat PC12 Cells , 2004, Pediatric Research.

[62]  Lin Lu,et al.  Cocaine seeking over extended withdrawal periods in rats: different time courses of responding induced by cocaine cues versus cocaine priming over the first 6 months , 2004, Psychopharmacology.

[63]  J. Alvarez‐Leite,et al.  Inhibition of ERK1/2 and CREB phosphorylation by caspase-dependent mechanism enhances apoptosis in a fibrosarcoma cell line treated with butyrate. , 2003, Biochemical and biophysical research communications.

[64]  D. Roberts,et al.  Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens , 1985, Pharmacology Biochemistry and Behavior.